http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9649284-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e32f3f10c636e659a4951024f9be125
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-10
filingDate 2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbda7c7d5263ad0292b78d2d002bbea1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d63fcaca397fd4efbe4a133dcd7f6834
publicationDate 2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9649284-B2
titleOfInvention Treating critically ill patients with intravenous ibuprofen
abstract Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.
priorityDate 2009-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03039532-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4861797-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004253244-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4859704-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5200558-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101217939-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008058302-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6727286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6005005-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009048345-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004132823-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6423746-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5463117-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004073653-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4309421-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009054413-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010015237-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6342530-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006142181-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006126214-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9704780-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4279926-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753

Total number of triples: 82.